Unconventional Pathways of Secretion Contribute to Inflammation
暂无分享,去创建一个
[1] K. Tracey,et al. Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation1 , 2000, The Journal of Immunology.
[2] Dirk E. Smith,et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. , 2009, Arthritis and rheumatism.
[3] L. Joosten,et al. Inflammasome activation and IL-1β and IL-18 processing during infection. , 2011, Trends in immunology.
[4] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[5] N. Mizushima,et al. Autophagy in mammalian development and differentiation , 2010, Nature Cell Biology.
[6] T. Bártfai,et al. An AP-1 site is involved in the NGF induction of IL-1α in PC12 cells , 1996, Neurochemistry International.
[7] G. López-Castejón,et al. Interleukin-1α expression precedes IL-1β after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissues , 2011, Journal of Neuroinflammation.
[8] C. Gabel,et al. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. , 1994, The Journal of biological chemistry.
[9] D. Edwards,et al. Nuclear accessory factors enhance the binding of progesterone receptor to specific target DNA , 1994, The Journal of Steroid Biochemistry and Molecular Biology.
[10] T. Rapoport. Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes , 2007, Nature.
[11] Jinfeng Liu,et al. Non-canonical inflammasome activation targets caspase-11 , 2011, Nature.
[12] K. Tracey,et al. Anti-HMGB1 Neutralizing Antibody Ameliorates Gut Barrier Dysfunction and Improves Survival after Hemorrhagic Shock , 2006, Molecular medicine.
[13] Chuan-Qi Zhong,et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion , 2015, Cell Research.
[14] C. Dinarello,et al. Interleukin-18 and IL-18 Binding Protein , 2013, Front. Immunol..
[15] T. Cai,et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death , 2015, Nature.
[16] M. Hersberger,et al. Fatty acid–induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis , 2013, Nature Immunology.
[17] S. Cullen,et al. Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α. , 2011, Molecular cell.
[18] E. Latz,et al. HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins , 2016, Cellular & Molecular Immunology.
[19] Joe D. Lewis,et al. Small Molecule Inhibitors Targeting Tec Kinase Block Unconventional Secretion of Fibroblast Growth Factor 2* , 2016, The Journal of Biological Chemistry.
[20] G. Dubyak,et al. Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages1 , 2007, The Journal of Immunology.
[21] W. Zong,et al. Activation of Poly(ADP)-ribose Polymerase (PARP-1) Induces Release of the Pro-inflammatory Mediator HMGB1 from the Nucleus* , 2007, Journal of Biological Chemistry.
[22] S. Cullen,et al. Diverse Activators of the NLRP3 Inflammasome Promote IL-1β Secretion by Triggering Necrosis. , 2015, Cell reports.
[23] R. Spreafico,et al. Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes , 2015, Nature Communications.
[24] L. Joosten,et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. , 2009, Blood.
[25] Boris Tefsen,et al. Regulation of expression and secretion of galectin-3 in human monocyte-derived dendritic cells. , 2009, Molecular immunology.
[26] J. Kuja-Panula,et al. Regulation of monocyte migration by amphoterin (HMGB1). , 2004, Blood.
[27] L. O’Neill,et al. The interleukin‐1 receptor/Toll‐like receptor superfamily: 10 years of progress , 2008, Immunological reviews.
[28] G. Criner,et al. Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. , 2015, Immunity.
[29] J. Kong,et al. Regulation of IL-1 Family Cytokines IL-1α, IL-1 Receptor Antagonist, and IL-18 by 1,25-Dihydroxyvitamin D3 in Primary Keratinocytes1 , 2006, The Journal of Immunology.
[30] M. Bianchi,et al. The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.
[31] B. Beutler,et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component , 2015, Nature Immunology.
[32] T. Simmet,et al. Intracellular Interleukin-1α Functionally Interacts with Histone Acetyltransferase Complexes* , 2004, Journal of Biological Chemistry.
[33] Kelly J. Morris,et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence , 2013, Nature Cell Biology.
[34] R. Kastelein,et al. IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex , 2007, The Journal of Immunology.
[35] J. Lieberman,et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores , 2016, Nature.
[36] C. Dinarello,et al. The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines , 2013, Front. Immunol..
[37] Kevin J. Tracey,et al. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.
[38] M. Bennett,et al. Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation , 2013, Immunity.
[39] G. Núñez,et al. K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. , 2013, Immunity.
[40] K. Matsushima,et al. Calcium-dependent binding of phosphorylated human pre interleukin 1 alpha to phospholipids. , 1990, Journal of biochemistry.
[41] J. Tschopp,et al. Autophagy Controls IL-1β Secretion by Targeting Pro-IL-1β for Degradation , 2011, The Journal of Biological Chemistry.
[42] Jeon-Soo Shin,et al. Nucleocytoplasmic Shuttling of HMGB1 Is Regulated by Phosphorylation That Redirects It toward Secretion1 , 2006, The Journal of Immunology.
[43] R. Flavell,et al. Caspase-1, Caspase-8, and Calpain Are Dispensable for IL-33 Release by Macrophages1 , 2009, The Journal of Immunology.
[44] E. Chi,et al. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. , 1995, The American journal of pathology.
[45] G. López-Castejón,et al. Understanding the mechanism of IL-1β secretion , 2011, Cytokine & growth factor reviews.
[46] S. Li,et al. Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis , 2014, Cell Death and Differentiation.
[47] W. Nickel,et al. Rerouting of fibroblast growth factor 2 to the classical secretory pathway results in post‐translational modifications that block binding to heparan sulfate proteoglycans , 2008, FEBS letters.
[48] H. Rauvala,et al. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. , 1991, The Journal of biological chemistry.
[49] M. Su,et al. Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme , 1997, Science.
[50] C. Dinarello,et al. Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses , 2014, Proceedings of the National Academy of Sciences.
[51] G. Fantuzzi,et al. IL-12–induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursor , 1999 .
[52] C. Dinarello,et al. IL-1α is a DNA damage sensor linking genotoxic stress signaling to sterile inflammation and innate immunity , 2015, Scientific Reports.
[53] R. Schekman,et al. Translocation of interleukin-1β into a vesicle intermediate in autophagy-mediated secretion , 2015, eLife.
[54] C. Gabel,et al. Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity , 2011, The Journal of Biological Chemistry.
[55] F. Di Virgilio,et al. The P2X7 Receptor: A Key Player in IL-1 Processing and Release1 , 2006, The Journal of Immunology.
[56] H. Hayashi,et al. The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL‐1α in human melanoma cells , 2008, Journal of leukocyte biology.
[57] Daniel R. Caffrey,et al. Cutting Edge: A Natural Antisense Transcript, AS-IL1α, Controls Inducible Transcription of the Proinflammatory Cytokine IL-1α , 2015, The Journal of Immunology.
[58] J. Kuemmerle-Deschner. CAPS — pathogenesis, presentation and treatment of an autoinflammatory disease , 2015, Seminars in Immunopathology.
[59] Q. Zhao,et al. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome , 2015, Molecular Neurobiology.
[60] L. French,et al. Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression , 2011, Proceedings of the National Academy of Sciences.
[61] E. Miao,et al. Reassessing the Evolutionary Importance of Inflammasomes , 2016, The Journal of Immunology.
[62] P. Nelson,et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation , 2015, Nature Cell Biology.
[63] J. Tschopp,et al. The Inflammasomes , 2010, Cell.
[64] M. Heneka,et al. NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.
[65] T. Yoshino,et al. Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[66] G. Dubyak,et al. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP , 2016, Nature Communications.
[67] Egil Lien,et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.
[68] S. Akira,et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release , 2010, Proceedings of the National Academy of Sciences.
[69] D. Green,et al. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. , 2008, Immunity.
[70] H. Kawasaki,et al. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[71] S. Akira,et al. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. , 1999, Immunity.
[72] P. Xiong,et al. Interleukin-33 is released in spinal cord and suppresses experimental autoimmune encephalomyelitis in mice , 2015, Neuroscience.
[73] Delphine A. Lacorre,et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.
[74] H. Harris,et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. , 2003, Arthritis and rheumatism.
[75] Christine E. Becker,et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes , 2010, Nature Immunology.
[76] Fernando Ontiveros,et al. The sterile inflammatory response. , 2010, Annual review of immunology.
[77] C. Dinarello,et al. Corrigendum: IL-1α is a DNA damage sensor linking genotoxic stress signaling to sterile inflammation and innate immunity , 2016, Scientific Reports.
[78] B. Ratliff,et al. High mobility group box 1 is a novel deacetylation target of Sirtuin1 , 2014, Kidney international.
[79] G. Fantuzzi,et al. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.
[80] L. Audoly,et al. Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.
[81] S. Brown,et al. Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. , 1993, The Journal of biological chemistry.
[82] E. Kubista,et al. Interleukin-1alpha protein secretion in breast cancer is associated with poor differentiation and estrogen receptor alpha negativity. , 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[83] Sally Freeman,et al. Inhibiting the Inflammasome: A Chemical Perspective. , 2016, Journal of medicinal chemistry.
[84] R. Hughes. Secretion of the galectin family of mammalian carbohydrate-binding proteins. , 1999, Biochimica et biophysica acta.
[85] H. Okamura,et al. Neutrophil Proteinase 3-Mediated Induction of Bioactive IL-18 Secretion by Human Oral Epithelial Cells1 , 2001, The Journal of Immunology.
[86] J. Bessa,et al. Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation. , 2014, Journal of autoimmunity.
[87] Ziying Wang,et al. HDAC4/5-HMGB1 signalling mediated by NADPH oxidase activity contributes to cerebral ischaemia/reperfusion injury , 2013, Journal of cellular and molecular medicine.
[88] Tiziana Bonaldi,et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.
[89] N. Rothwell,et al. The Dynamics and Mechanisms of Interleukin-1α and β Nuclear Import , 2008, Traffic.
[90] C. Gabel,et al. Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors. , 2001, The Journal of pharmacology and experimental therapeutics.
[91] J. Melendez,et al. Redox Control of the Senescence Regulator Interleukin-1α and the Secretory Phenotype* , 2013, The Journal of Biological Chemistry.
[92] M. Bergeron,et al. Role of Galectin-3 as an Adhesion Molecule for Neutrophil Extravasation During Streptococcal Pneumonia1 , 2002, The Journal of Immunology.
[93] D. Brough,et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models , 2016, Nature Communications.
[94] Ryan E. Mills,et al. Expanding the Definition of the Classical Bipartite Nuclear Localization Signal , 2010, Traffic.
[95] G. López-Castejón,et al. Caspase-1: is IL-1 just the tip of the ICEberg? , 2012, Cell Death and Disease.
[96] D. Rifkin,et al. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum‐Golgi complex , 1992, Journal of cellular physiology.
[97] W. Nickel,et al. Unconventional secretion of fibroblast growth factor 2--a novel type of protein translocation across membranes? , 2015, Journal of molecular biology.
[98] Denise N. Bronner,et al. Endoplasmic Reticulum stress activates the inflammasome via NLRP 3-caspase-2 driven mitochondrial damage , 2015 .
[99] Katherine A. Fitzgerald,et al. Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes , 2014, Cell.
[100] Carolin Stegmayer,et al. Unconventional secretion of fibroblast growth factor 2 and galectin‐1 does not require shedding of plasma membrane‐derived vesicles , 2008, FEBS letters.
[101] B. Krantz,et al. Pyroptosis triggers pore-induced intracellular traps (PITs) that capture bacteria and lead to their clearance by efferocytosis , 2016, The Journal of experimental medicine.
[102] F. Cozzolino,et al. A novel secretory pathway for interleukin‐1 beta, a protein lacking a signal sequence. , 1990, The EMBO journal.
[103] J. Walters,et al. Stimulation of interleukin-1 alpha and interleukin-1 beta production in human monocytes by protein phosphatase 1 and 2A inhibitors. , 1993, The Journal of biological chemistry.
[104] M. Kaghad,et al. Human interleukin 1 beta fused to the human growth hormone signal peptide is N-glycosylated and secreted by Chinese hamster ovary cells. , 1991, Gene.
[105] Takeshi Mizutani,et al. Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity , 2014, Science.
[106] The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses , 2011, The Journal of Immunology.
[107] Alan Wells,et al. m-calpain Activation Is Regulated by Its Membrane Localization and by Its Binding to Phosphatidylinositol 4,5-Bisphosphate* , 2010, The Journal of Biological Chemistry.
[108] A. Aguzzi,et al. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice , 1999, Nature Genetics.
[109] Mingcai Li,et al. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. , 2009, Biochemical and biophysical research communications.
[110] J. Girard,et al. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1 , 2009, Proceedings of the National Academy of Sciences.
[111] Heshui Wu,et al. PARP-1 Mediates LPS-Induced HMGB1 Release by Macrophages through Regulation of HMGB1 Acetylation , 2014, The Journal of Immunology.
[112] Reid C. Johnson,et al. Determinants of HMGB Proteins Required To Promote RAG1/2-Recombination Signal Sequence Complex Assembly and Catalysis during V(D)J Recombination , 2005, Molecular and Cellular Biology.
[113] B. Cookson,et al. Pyroptosis: host cell death and inflammation , 2009, Nature Reviews Microbiology.
[114] N. Rothwell,et al. Caspase-1-dependent processing of pro-interleukin-1β is cytosolic and precedes cell death , 2007, Journal of Cell Science.
[115] Dacheng Wang,et al. Pore-forming activity and structural autoinhibition of the gasdermin family , 2016, Nature.
[116] P. Mercier,et al. Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33–LacZ Gene Trap Reporter Strain , 2012, The Journal of Immunology.
[117] E. Voronov,et al. The transcription of the alarmin cytokine interleukin-1 alpha is controlled by hypoxia inducible factors 1 and 2 alpha in hypoxic cells , 2012, Front. Immun..
[118] C. Dinarello,et al. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[119] E. S. Baekkevold,et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. , 2003, The American journal of pathology.
[120] D. Golenbock,et al. Hemolysis-induced lethality involves inflammasome activation by heme , 2014, Proceedings of the National Academy of Sciences.
[121] Catherine Rabouille,et al. Mechanisms of regulated unconventional protein secretion , 2009, Nature Reviews Molecular Cell Biology.
[122] H. Fukuhara,et al. High-level secretion of correctly processed recombinant human interleukin-1 beta in Kluyveromyces lactis. , 1991, Gene.
[123] A. Rami,et al. Spatial resolution of phospholipid scramblase 1 (PLSCR1), caspase-3 activation and DNA-fragmentation in the human hippocampus after cerebral ischemia , 2003, Neurochemistry International.
[124] J. Girard,et al. The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’? , 2008, PloS one.
[125] S. Akira,et al. Leishmania major activates IL-1α expression in macrophages through a MyD88-dependent pathway , 2002 .
[126] J. Tschopp,et al. Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1. , 2012, Immunity.
[127] R. Hughes,et al. Plasma membrane targetting, vesicular budding and release of galectin 3 from the cytoplasm of mammalian cells during secretion. , 1997, Journal of cell science.
[128] Gabriel A. Rabinovich,et al. Galectins as modulators of tumour progression , 2005, Nature Reviews Cancer.
[129] I. McInnes,et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells , 2008, Proceedings of the National Academy of Sciences.
[130] L. Carruth,et al. Involvement of a calpain-like protease in the processing of the murine interleukin 1 alpha precursor. , 1991, The Journal of biological chemistry.
[131] K. Schroder,et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases , 2015, Nature Medicine.
[132] J. Symons,et al. Human interleukin-1α gene expression is regulated by Sp1 and a transcriptional repressor , 2005 .
[133] A. Rubartelli,et al. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way , 2008, Proceedings of the National Academy of Sciences.
[134] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[135] N. Mori,et al. Transactivation of the interleukin-1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins. , 1996, Blood.
[136] M. Torrisi,et al. The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. , 1999, Molecular biology of the cell.
[137] N. Rothwell,et al. Release of Interleukin-1α or Interleukin-1β Depends on Mechanism of Cell Death* , 2014, The Journal of Biological Chemistry.
[138] B. McColl,et al. Nuclear retention of IL‐1α by necrotic cells: A mechanism to dampen sterile inflammation , 2009, European journal of immunology.
[139] Klaus Ersfeld,et al. The calpains: modular designs and functional diversity , 2007, Genome Biology.
[140] A. Ohtsuka,et al. Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood–Brain Barrier From Ischemia-Induced Disruption in Rats , 2011, Stroke.
[141] M. Künzler,et al. Cell surface counter receptors are essential components of the unconventional export machinery of galectin-1 , 2005, The Journal of cell biology.
[142] I. Ugrinova,et al. The DNA Binding and Bending Activities of Truncated Tail-less HMGB1 protein are Differentially Affected by Lys-2 and Lys-81 Residues and Their Acetylation , 2011, International journal of biological sciences.
[143] K. Prickett,et al. The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. , 1987, The Journal of biological chemistry.
[144] Dhruv Chauhan,et al. A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation* , 2015, The Journal of Biological Chemistry.
[145] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[146] V. Deretic,et al. Autophagy‐based unconventional secretory pathway for extracellular delivery of IL‐1β , 2011, The EMBO journal.
[147] A. C. Webb,et al. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[148] D. Brough,et al. P2X7R activation drives distinct IL-1 responses in dendritic cells compared to macrophages , 2015, Cytokine.
[149] C. Colnot,et al. Maintenance of granulocyte numbers during acute peritonitis is defective in galectin‐3‐null mutant mice , 1998, Immunology.
[150] S. Mohr,et al. P2X7 Receptor-Stimulated Secretion of MHC Class II-Containing Exosomes Requires the ASC/NLRP3 Inflammasome but Is Independent of Caspase-1 1 , 2009, The Journal of Immunology.
[151] G. Goodwin,et al. Physical studies of the nonhistone chromosomal proteins HMG-U and HMG-2. , 1976, Biochemistry.
[152] Y. Carmi,et al. Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation , 2010, Proceedings of the National Academy of Sciences.
[153] Sunny Shin,et al. Caspase-11 Activation in Response to Bacterial Secretion Systems that Access the Host Cytosol , 2013, PLoS pathogens.
[154] R. Reeves,et al. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. , 1996, Progress in nucleic acid research and molecular biology.
[155] K. Tracey,et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. , 2003, American journal of physiology. Cell physiology.
[156] A. Ingham,et al. Trichostrongylus colubriformis larvae induce necrosis and release of IL33 from intestinal epithelial cells in vitro: implications for gastrointestinal nematode vaccine design. , 2012, International journal for parasitology.
[157] D. Rifkin,et al. Biological roles of fibroblast growth factor-2. , 1997, Endocrine reviews.
[158] Seamus J. Martin. Cell death and inflammation: the case for IL‐1 family cytokines as the canonical DAMPs of the immune system , 2016, The FEBS journal.
[159] T. Nyman,et al. Calpain Activity Is Essential for ATP-Driven Unconventional Vesicle-Mediated Protein Secretion and Inflammasome Activation in Human Macrophages , 2016, The Journal of Immunology.
[160] S. Barondes,et al. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism , 1990, The Journal of cell biology.
[161] V. Malhotra,et al. Diversity in unconventional protein secretion , 2012, Journal of Cell Science.
[162] S. Akira,et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells , 2007, Nature Medicine.
[163] B. Spellberg,et al. Type 1/Type 2 immunity in infectious diseases. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[164] S. Kummerfeld,et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.
[165] M. Schmitz,et al. The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-κB To Dampen NF-κB–Stimulated Gene Transcription , 2011, The Journal of Immunology.
[166] J. E. Ford,et al. Cloning and Characterization of IL-1HY2, a Novel Interleukin-1 Family Member* , 2001, The Journal of Biological Chemistry.
[167] F. Martinon,et al. Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.
[168] Jason P. Zlotnicki,et al. High Mobility Group Box 1 Release from Hepatocytes during Ischemia and Reperfusion Injury Is Mediated by Decreased Histone Deacetylase Activity* , 2010, The Journal of Biological Chemistry.
[169] R. Schekman,et al. Bi-directional protein transport between the ER and Golgi. , 2004, Annual review of cell and developmental biology.
[170] K. Moore,et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.
[171] L. Roussel,et al. Molecular mimicry between IL‐33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocket , 2008, EMBO reports.
[172] Judith Campisi,et al. Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network , 2009, Proceedings of the National Academy of Sciences.
[173] D. Brough,et al. Inflammasome-dependent IL-1β release depends upon membrane permeabilisation , 2016, Cell Death and Differentiation.
[174] J. Armstrong,et al. The trans Golgi Network Is Lost from Cells Infected with African Swine Fever Virus , 2001, Journal of Virology.
[175] U. Andersson,et al. RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages , 2005, Scandinavian journal of immunology.
[176] K. Jeng,et al. An endogenous lectin, galectin-3 (epsilon BP/Mac-2), potentiates IL-1 production by human monocytes. , 1994, Immunology letters.
[177] C. Baglioni,et al. Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[178] N. Rothwell,et al. Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology , 2012, Disease Models & Mechanisms.
[179] L. Yu,et al. This information is current as Macrophages Chemoattractant for Monocytes and Human Galectin-3 Is a Novel , 2000 .
[180] Carolin Stegmayer,et al. Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells , 2002, Journal of Cell Science.
[181] Qutayba Hamid,et al. Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells1 , 2009, The Journal of Immunology.